These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32946877)

  • 21. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
    Twaroski K; Eide C; Riddle MJ; Xia L; Lees CJ; Chen W; Mathews W; Keene DR; McGrath JA; Tolar J
    Br J Dermatol; 2019 Dec; 181(6):1247-1253. PubMed ID: 30924923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin.
    Bremer J; van den Akker PC
    Methods Mol Biol; 2022; 2434():315-320. PubMed ID: 35213027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel and very rare causative variants in the COL7A1 gene of Vietnamese patients with recessive dystrophic epidermolysis bullosa revealed by whole-exome sequencing.
    Ma THT; Luong TLA; Hoang TL; Nguyen TTH; Vu TH; Tran VK; Nguyen DB; Trieu TS; Nguyen HH; Nong VH; Nguyen DT
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1748. PubMed ID: 34286919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five Novel
    Yan Y; Meng Z; Hao S; Wang F; Jin X; Sun D; Gao H; Ma X
    Ann Clin Lab Sci; 2018 Jan; 48(1):100-105. PubMed ID: 29531004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dystrophic epidermolysis bullosa phenotypes in a large consanguineous Tunisian family.
    Ouragini H; Cherif F; Kassar S; Floriddia G; Pascucci M; Daoud W; Osman-Dhahri AB; Boubaker S; Castiglia D; Abdelhak S
    J Dermatol Sci; 2009 May; 54(2):114-20. PubMed ID: 19261445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.
    Bonafont J; Mencía Á; García M; Torres R; Rodríguez S; Carretero M; Chacón-Solano E; Modamio-Høybjør S; Marinas L; León C; Escamez MJ; Hausser I; Del Río M; Murillas R; Larcher F
    Mol Ther; 2019 May; 27(5):986-998. PubMed ID: 30930113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
    J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splice modulation strategy applied to deep intronic variants in
    Pironon N; Bourrat E; Prost C; Chen M; Woodley DT; Titeux M; Hovnanian A
    Proc Natl Acad Sci U S A; 2024 Aug; 121(35):e2401781121. PubMed ID: 39159368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense-mediated exon skipping to reframe transcripts.
    Turczynski S; Titeux M; Pironon N; Hovnanian A
    Methods Mol Biol; 2012; 867():221-38. PubMed ID: 22454065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.
    Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H
    Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
    Primerano A; De Domenico E; Cianfarani F; De Luca N; Floriddia G; Teson M; Cristofoletti C; Cardarelli S; Scaglione GL; Baldini E; Cangelosi D; Uva P; Reinoso Sánchez JF; Roubaty C; Dengjel J; Nyström A; Mastroeni S; Ulisse S; Castiglia D; Odorisio T
    Br J Dermatol; 2024 Sep; 191(4):568-579. PubMed ID: 38820176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
    Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A
    J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY; Nazaroff J; Iwummadu CV; Harris N; Gorell ES; Fulchand S; Bailey I; McCarthy D; Siprashvili Z; Marinkovich MP; Tang JY; Chiou AS
    Orphanet J Rare Dis; 2022 Oct; 17(1):377. PubMed ID: 36253825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic studies of 20 Japanese families of dystrophic epidermolysis bullosa.
    Sawamura D; Goto M; Yasukawa K; Sato-Matsumura K; Nakamura H; Ito K; Nakamura H; Tomita Y; Shimizu H
    J Hum Genet; 2005; 50(10):543-546. PubMed ID: 16189623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Hong SA; Kim SE; Lee AY; Hwang GH; Kim JH; Iwata H; Kim SC; Bae S; Lee SE
    Mol Ther; 2022 Aug; 30(8):2664-2679. PubMed ID: 35690907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells.
    Matsuda A; Hasegawa T; Ikeda Y; Wada A; Ikeda S
    J Dermatol Sci; 2024 Jul; 115(1):42-50. PubMed ID: 38876908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort.
    Gupta D; Jayashankar C; Srinivas M; Baraka Vishwanathan G; Reddy KR; Kubba A; Batrani M; Hiremagalore R
    PLoS One; 2023; 18(8):e0289558. PubMed ID: 37556444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense-Mediated Splice Modulation to Reframe Transcripts.
    Titeux M; Turczynski S; Pironon N; Hovnanian A
    Methods Mol Biol; 2018; 1828():531-552. PubMed ID: 30171566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.